- Listed price
- $399
- Member headline
- $159; conditions and complete cost need confirmation
- Subscription label
- $399 every 10 weeks
A storefront that needs more than one number
Regenics publishes a sermorelin injection listing with both an ordinary $399 price and a $159 member price. The page also offers a one-time purchase choice and a subscription labeled $399 every ten weeks. These are distinct pieces of commercial information. Combining the lowest number with the most convenient billing interval would create an offer the page does not clearly establish.
We reviewed the rendered storefront and its product information rather than completing checkout. The unresolved issue is how membership changes the actual charge, including whether membership itself costs extra and which conditions apply. Our register uses the visible $399 listing while explaining the lower member offer alongside it, rather than presenting $159 as an unrestricted monthly price.
Identify the current product by its label
The reviewed page labels the product as a 15 mg injectable even though its address still contains the text 9mg. An older-looking URL is not a reliable description of the current selectable product. Readers should use the current prescription, order confirmation and pharmacy label to resolve the identity of what will actually be supplied.
This distinction matters beyond search-engine wording. Total milligrams in a vial, concentration and the volume after preparation are different measurements. The public listing states that concentration can vary by pharmacy while total milligrams remain consistent. That is a reason to confirm the dispensing details, not to reconstruct an administration schedule from the storefront.
What the package advertises
Regenics says the injection offering includes medication, syringes, alcohol pads and instructions. Those named items help define the package, but the checked page does not settle every potential care cost. Ask whether the clinical assessment, laboratory work, follow-up and shipping are covered by the particular purchase option selected.
The ten-week subscription label should be read as a billing condition. It does not establish that every patient should use a vial for ten weeks or continue treatment for a particular duration. Ask how a prescription change, a delayed refill or a clinician's decision to stop treatment interacts with the next scheduled payment.
Regulatory language and clinical claims
The provider identifies the compounded product as not FDA-approved and requires a licensed prescriber's involvement. Its public material also acknowledges limits around anti-aging and performance uses. Readers should not interpret any historical mention of sermorelin approval as approval of this current preparation or as evidence for every benefit described in marketing.
The relevant clinical question is why a particular patient is being evaluated and what evidence supports the proposed care. Endocrine guidance on adult growth-hormone deficiency does not turn ordinary fatigue or aging into a diagnosis. We did not verify clinical outcomes among Regenics patients, inspect its pharmacy operations or conduct an independent comparison of its finished product.
What would make the quote decision-ready
Request an itemized estimate showing the selected product, membership requirements, initial total and future billing. Ask specifically whether the member headline changes the displayed ten-week subscription charge. The answer should be written clearly enough that another person could calculate the commitment without inferring how two separate prices relate.
Regenics adds a useful example of why a transparent comparison must retain uncertainty when a storefront presents several price cues. Its publicly listed supplies and prescription requirement are relevant facts. Its complete cost and renewal conditions still need confirmation before the lower member number can be compared fairly with another provider's standard package.
Useful distinctions
- One-time and subscription choices visible
- Medication and basic supplies named
- Compounding status disclosed
Limitations to weigh
- Member offer and subscription amount are not reconciled
- Assessment, lab and shipping costs need confirmation
- Current product label differs from legacy URL text
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.